Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial (Q34207762)

31 July 2017

Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial (English)

1 reference

31 July 2017

Solomon Tesfaye

19

0 references

Christopher J. Klein

object named as

Christopher J Klein

13

0 references

author name string

Peter J Dyck

1

1 reference

31 July 2017

Carol J Overland

2

1 reference

31 July 2017

Phillip A Low

3

1 reference

31 July 2017

William J Litchy

4

1 reference

31 July 2017

Jenny L Davies

5

1 reference

31 July 2017

P James B Dyck

6

1 reference

31 July 2017

Peter C O'Brien

7

1 reference

31 July 2017

Cl vs. NPhys Trial Investigators

8

1 reference

31 July 2017

James W Albers

9

1 reference

31 July 2017

Henning Andersen

10

1 reference

31 July 2017

Charles F Bolton

11

1 reference

31 July 2017

John D England

12

1 reference

31 July 2017

J Gareth Llewelyn

14

1 reference

31 July 2017

Michelle L Mauermann

15

1 reference

31 July 2017

James W Russell

16

1 reference

31 July 2017

Wolfgang Singer

17

1 reference

31 July 2017

A Gordon Smith

18

1 reference

31 July 2017

Adrian Vella

20

1 reference

31 July 2017

1 August 2010

1 reference

31 July 2017

1 reference

31 July 2017

42

1 reference

31 July 2017

2

1 reference

31 July 2017

157-164

1 reference

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Electrophysiological studies in diabetic neuropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956592

Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies

28 October 2018

1 reference

12 December 2020

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

12 December 2020

Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment

1 reference

12 December 2020

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

12 December 2020

Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association

1 reference

12 December 2020

Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects

1 reference

12 December 2020

Diabetic polyneuropathy in controlled clinical trials: Consensus Report of the Peripheral Nerve Society

1 reference

12 December 2020

Reproducibility of different nerve conduction velocity measurements in healthy test subjects and patients suffering from diabetic polyneuropathy

1 reference

12 December 2020

The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients

1 reference

12 December 2020

Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity

1 reference

12 December 2020

Identifiers

DOI

10.1002/MUS.21661

1 reference

31 July 2017

1 reference

31 July 2017

1 reference